Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vitthal Sawant"'
Publikováno v:
International Journal of Scientific Research in Computer Science, Engineering and Information Technology. :76-84
Waste collection and resource management on time has been always a challenge rather efficient collection of waste by corporation. This project aims to achieve this goal with help of Internet of Things and mobile application and intend to retrieve dat
Autor:
M.V.N. Kumar Talluri, Vitthal Sawant, Srinivas Ragampeta, Balasaheb B. Chavan, Roshan M. Borkar
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 166:139-146
Afatinib is an irreversible tyrosine kinase receptor inhibitor which was approved lately by USFDA for the treatment of metastatic non-small cell lung cancer (NSCLC). AFT was subjected to stress degradation studies under hydrolytic (acid, base and neu
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Satish Vitthal Sawant, Yatish K Bansal, Sonal S Kadam, Suhas S Khandave, Santosh Shrikrishna Joshi
Publikováno v:
Drug Design, Development and Therapy
Suhas S Khandave1, Satish V Sawant1, Santosh S Joshi1, Yatish K Bansal2, Sonal S Kadam21Accutest Research Laboratories (I) Private Limited, Koparkhirne, Navi Mumbai, Maharashtra, India; 2Ipca Laboratories Limited, Kandivli Mumbai, Maharashtra, IndiaB
Autor:
ave, Satish Vitthal Sawant, Santosh Shrikrishna Joshi, Suhas Sahebrao Kh, Shahoo Vasant Onkar
Publikováno v:
Journal of Bioequivalence & Bioavailability.
Background and objective: The existing fixed-dose combination, Coartem® (artemether 20 mg and lumefantrine 80 mg) requires 4 tablets per dose and a total of 24 tablets for the six-dose regimen for the treatment of uncomplicated P. falciparum malaria
Autor:
Satish Vitthal Sawant, Shahoo Vasant Onkar, Suhas Sahebrao Kh, ave, Santosh Shrikrishna Joshi
Publikováno v:
Journal of Bioequivalence & Bioavailability.
Background and Objective: Prolonged pharmacokinetic sampling is a challenge for successful conduction of the bioequivalence studies for drugs having long elimination half-lives. The regulatory authorities have recommended an alternative to consider t